• 1
    Johnson GS, Turrentine MA, Kraus KH. Canine von Wille-brand's disease: A heterogeneous group of bleeding disorders. Vet Clin North Am 1988; 18:195229.
  • 2
    Dalton RG, Dewar MS, Savidge GF, et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet 1987:1;10071009.
  • 3
    Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med 1982;97:713716.
  • 4
    Palareti G., Biagi G., Legnani C., et al. Association of reduced factor VIlt with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy. Thromb Haemost 1989;62:10531056.
  • 5
    Budde U., Schaefer G., Mueller N., et al. Acquired von Willebrand's disease in myeloproliferative syndromes. Blood 1984;64:981985.
  • 6
    Budde U., Scharf RE, Franke P., et al. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood 1993;82:17491757.
  • 7
    Stewart AK, Glynn MF. Acquired von Willebrand disease associated with free lambda light chain monoclonal gammopathy, normal bleeding time and response to prednisone. Postgrad Med J 1990;66:560562.
  • 8
    Mant MJ, Hirsch J., Gauldie J., et al. Von Willebrand syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammopathy. Blood 1973;42:429436.
  • 9
    Coppes MJ, Zandvoort SW, Sparling CR, et al. Acquired von Willebrand disease in Wilms' tumor patients. J Clin Oncol 1992;10:422427.
  • 10
    Facon T., Caron C., Courtin P., et al. Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma. Br J Haematol 1992;80:488494.
  • 11
    Pizzuto J., Ambriz R., de la Paz Reyna J., et al. Acquired von Willebrand syndrome during autoimmune disorder. Thromb Haemost 1980;42:15231528.
  • 12
    Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: Is acquired von Willebrand's disease the link? Lancet 1992;340:3537.
  • 13
    Bloom AL. Von Willebrand factor: Clinical features of inherited and acquired disorders. Mayo Clin Proc 1991;66:743751.
  • 14
    Avgeris S., Lothrop CD, McDonald TP. Plasma von Willebrand factor concentration and thyroid function in dogs. J Am Vet Med Assoc 1990; 196:921924.
  • 15
    Dodds WJ. Von Willebrand's disease in dogs. Mod Vet Pract 1984:681686.
  • 16
    Dodds WJ. Contributions and future directions of hemostasis research. J Am Vet Med Assoc 1988; 193:11571160.
  • 17
    Panciera DL, Johnson GS. Plasma von Willebrand factor antigen concentration in dogs with hypothyroidism. J Am Vet Med Assoc 1994;205:15501553.
  • 18
    Lumsden JH, O'Grady MR, Johnstone IB, et al. Prevalence of hypothyroidism and von Willebrands disease in doberman pinschers and the observed relationship between thyroid, von Willebrand and cardiac status. J Vet Intern Med 1993;7:115 (abstr).
  • 19
    Johnstone IB, O'Grady MR, Lumsden JH, et al. Thyroid supplementation effect on plasma von Willebrand factodfactor VIII in doberman pinschers. J Vet Intern Med 1993;7:130 (abstr).
  • 20
    Ching YNHL, Meyers KM, Brassard JA, et al. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimers and bleeding time in Doberman Pinschers with type-I von Willebrand's disease. Am J Vet Res 1994;55:102110.
  • 21
    Kraus KH, Turrentine MA, Jergens AE, et al. Effect of desmopressin acetate on bleeding times and plasma von Willebrand factor in Doberman Pinscher dogs with von Willebrand's disease. Vet Surg 1989;18:103109.
  • 22
    Jergens AE, Turrentine MA, Kraus KH, et al. Buccal mucosa bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand's disease. Am J Vet Res 1987;48:13371342.
  • 23
    Brassard JA, Meyers KM. Von Willebrand factor is not altered in azotemic dogs with prolonged bleeding time. J Lab Clin Med 1994; 124:5.5–62.
  • 24
    Zeigler ZR, Hasiba U., Lewis JH, et al. Hemostatic defects in response to aspirin challenge in hypothyroidism. Am J Hematol 1986;23:391399.
  • 25
    Wood RW, Martis L., Gillum AW, et al. In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog model. J Pharm Sci 1990; 79:124127.
  • 26
    Ganjam VK, Wykoff JT, Comerci CA, et al. Recrudescence of extra-thyroidal tissue, T4 and T3 kinetics following thyroidectomy and effects of replacement therapy in the canine. Fed Proc 1980; 39:947 (abstr).
  • 27
    Panciera DL, Post K. Effect of oral administration of sulfadia-zine and trimethoprim in combination on thyroid function in dogs. Can J Vet Res 1992;56:349352.
  • 28
    Schlink GT, Johnson GS. A sensitive autoradiographic procedure for factor VIII-related antigen in canine plasma. Vet Clin Pathol 1983; 12:2127.
  • 29
    Badylak SF, Dodds WJ, van Vleet JF. Plasma coagulation factor abnormalities in dogs with naturally occurring hepatic disease. Am J Vet Res 1983;44:23362340.
  • 30
    Zimmerman RS, Ryan J., Edwards BS, et al. Cardiorenal endocrine dynamics during volume expansion in hypothyroid dogs. Am J Physiol 1988; 255:R61R66.
  • 31
    Handin RI, Marin V., Molony WC. Antibody-induced von Willebrand's disease. A newly defined inhibitor syndrome. Blood 1976;48:395405.